Damian Colin Bell

Title: Damian Colin Bell: Innovator in Sodium Channel Inhibitors

Introduction

Damian Colin Bell is a notable inventor based in Sawston, GB. He has made significant contributions to the field of medicine through his innovative work on sodium channel inhibitors. His research focuses on the development of binding members for sodium channel Nav1.7, which have potential applications in treating pain and epilepsy.

Latest Patents

Damian holds 1 patent related to his work. His patent details the design of binding members that comprise a fusion protein containing a Nav1.7-binding peptide, such as a venom toxin peptide or knottin, inserted within an antibody variable domain. This innovative approach enhances the specificity of binding to Nav1.7 over other sodium channels, which is crucial for effective medical treatments.

Career Highlights

Damian is currently associated with Maxion Therapeutics Limited, where he continues to advance his research in sodium channel inhibitors. His work is pivotal in the ongoing quest to develop more effective treatments for conditions like pain and epilepsy.

Collaborations

Damian collaborates with esteemed colleagues, including Aneesh Karatt Vellatt and John Mccafferty. Their combined expertise contributes to the innovative research environment at Maxion Therapeutics Limited.

Conclusion

Damian Colin Bell's contributions to the field of sodium channel inhibitors exemplify the impact of innovative research in medicine. His work not only advances scientific understanding but also holds promise for improving patient care in the future.